We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 01, 2020

Impaired Spermatogenesis and Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma

JAMA Oncology

 

Additional Info

JAMA Oncology
Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma
JAMA Oncol 2020 Jun 18;[EPub Ahead of Print], JM Scovell, K Benz, I Samarska, TP Kohn, JE Hooper, A Matoso, AS Herati

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading